Beyond Medical Group
PrivateLast Round
Private Equity
Oct 26, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Beyond Medical Group operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Private Equity round in October 2022.
Beyond Medical Group is a healthcare services company that operates a network of multispecialty clinics and provides comprehensive clinic management and administrative support to medical practitioners in Singapore.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Fashion & Beauty
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beyond Medical Group Comparables
Compare Beyond Medical Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Crawfurd Medical Centre | 90% | |
| Nuffield Medical | 86% | |
| Bethesda Medical | 86% |
For institutional investors. Book with your work email.
Beyond Medical Group Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Beyond Medical Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AltaIR Capital | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM, reaching 3.3K.
- Jul 27, 2026
Monthly visitors increased 48% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 11, 2026
Beyond Medical Group and Singmed formalise a strategic partnership in Cambodia on Nov 10th '26 to expand regional healthcare collaboration and establish coordinated pathways for specialist consultation, multidisciplinary care and treatment across Singapore and Cambodia.
- expands_offices_toSep 24, 2026
Beyond Medical Group plans to expand its offices to Manila by establishing a representative office operated by a subsidiary, with renovation underway and opening expected in Jan '27 to support information, appointments and coordination for people exploring specialist care in Singapore.
For institutional investors. Book with your work email.
Beyond Medical Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beyond Medical Group's valuation, stock price, and market status.
Is Beyond Medical Group a public or private company?
Beyond Medical Group is a private company.
What is the current stock price of Beyond Medical Group?
Beyond Medical Group is a private company, so its shares have no public market price. Caplight tracks Beyond Medical Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beyond Medical Group worth (valuation)?
Valuation information for Beyond Medical Group is not publicly available.
Can I buy Beyond Medical Group stock?
Beyond Medical Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beyond Medical Group's last funding round?
Beyond Medical Group's most recent funding round was Private Equity on October 26, 2022.
Who are the main investors in Beyond Medical Group?
Key investors in Beyond Medical Group include AltaIR Capital.
Will Beyond Medical Group IPO soon?
No public IPO plans have been announced for Beyond Medical Group.
How can I track Beyond Medical Group secondary market activity?
Caplight tracks bids, offers, and trades in Beyond Medical Group's shares on secondary markets.